Microbial diversity, otitis media, and the pneumococcal transctiptome
微生物多样性、中耳炎和肺炎球菌转录组
基本信息
- 批准号:8290218
- 负责人:
- 金额:$ 20.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:3 year oldAcuteAge-YearsAntibioticsBacteriaBiodiversityBioinformaticsBiological Response Modifier TherapyBiologyCell LineChildChildhoodClinicalComplexCross-Sectional StudiesDataDetectionDevelopmentDiseaseEpithelial CellsGenesGenomeHaemophilus influenzaeHealthHumanIncidenceInfectionInvadedLeadMeningitisMethodologyMethodsMinorMonitorNIH Program AnnouncementsNational Institute on Deafness and Other Communication DisordersNoseOtitis MediaOutcomePathway interactionsPatternPhiladelphiaPneumococcal 7-Valent Conjugate VaccinePneumococcal ColonizationPneumoniaPrevention strategyPreventiveProbioticsProcessProtocols documentationRNARNA SequencesRelative (related person)ResearchRespiratory SystemRespiratory tract structureRiskSamplingSeasonsSignal TransductionSiteStimulusStreptococcus pneumoniaeStructureStructure of mucous membrane of noseTaxonTherapeuticTissuesTranscriptUpper Respiratory InfectionsUpper respiratory tractViral Respiratory Tract InfectionVirulencecDNA Librarydesigneffective therapyinsightmembermicrobialmicrobial communitynovelnovel strategiesnovel vaccinespathogenrRNA Genesresiliencerespiratory virusresponsetheoriestreatment strategyvaccination strategy
项目摘要
DESCRIPTION (provided by applicant): Streptococcus pneumoniae asymptomatically colonizes the upper respiratory tract of healthy young children and is a leading cause of acute otitis media (OM). S. pneumoniae colonization is a critical step in the disease process and occurs in the context of a complex microbial community. Limited understanding of the relationships between bacterial colonization patterns and risk of OM has hindered the development of preventive and therapeutic strategies that maximize clinical outcomes and minimize disruptions to the protective commensal flora. Our proposed studies are in direct response to the NIDCD Program Announcement (PA-08-092) "Novel Approaches to Study Polymicrobial Diseases". We will analyze pre-existing data from a cross sectional study of 249 Philadelphia children 6 months to =3 years of age. Samples and data were collected during the 2009-10 winter respiratory virus season. High throughput 454 16S rRNA gene pyrosequencing will be used to characterize nasal microbial communities. RNA-sequencing (RNA-seq) on the Illumina Genome Analyzer 2 platform will be used to compare S. pneumoniae transcriptional profiles under a range of experimental conditions. Our specific aims are: 1) To characterize upper respiratory tract microbial community structure in a cross sectional sample of healthy children, children with acute OM, and children with other, primarily non-bacterial upper respiratory tract infections, which often precede the onset of acute OM and 2) To develop RNA- seq protocols and bioinformatics pipelines to study S. pneumoniae transcriptional profiles, alone and in the presence of key commensal species. These studies will identify members of the normal flora involved in the causal pathogenic pathway of S. pneumoniae colonization and acute OM. New methods will be developed to identify S. pneumoniae virulence genes uniquely expressed in polymicrobial settings. Over the long term these data will aid in the development of biotherapeutics such as probiotics and will also provide information relevant for the control of other bacterial pathogens that colonize the respiratory tract.
描述(由申请方提供):肺炎链球菌无症状地定植于健康幼儿的上呼吸道,是急性中耳炎(OM)的主要原因。S.肺炎菌定殖是疾病过程中的关键步骤,并且发生在复杂微生物群落的背景下。对细菌定植模式与OM风险之间关系的了解有限,阻碍了预防和治疗策略的发展,这些策略可最大限度地提高临床结局,并最大限度地减少对保护性植物植物群的破坏。我们提出的研究是对NIDCD计划公告(PA-08-092)“研究多微生物疾病的新方法”的直接响应。我们将分析来自249名6个月至3岁以下费城儿童的横断面研究的现有数据。在2009-10年冬季呼吸道病毒季节收集样本和数据。高通量454 16 S rRNA基因焦磷酸测序将用于表征鼻腔微生物群落。将使用Illumina Genome Analyzer 2平台上的RNA测序(RNA-seq)比较S. pneumoniae的转录谱。我们的具体目标是:1)表征健康儿童、患有急性OM的儿童和患有其他主要非细菌性上呼吸道感染的儿童的横截面样品中的上呼吸道微生物群落结构,其通常在急性OM发作之前,和2)开发RNA-seq方案和生物信息学管道以研究S. pneumoniae的转录谱,单独和在关键物种的存在下。这些研究将确定参与沙门氏菌致病途径的正常植物群的成员。肺炎定植和急性OM。新的方法将被开发用于鉴定S。在多微生物环境中唯一表达的肺炎毒力基因。从长远来看,这些数据将有助于开发生物治疗药物,如益生菌,还将提供与控制呼吸道定植的其他细菌病原体相关的信息。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Melinda Mary Pettigrew其他文献
Melinda Mary Pettigrew的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Melinda Mary Pettigrew', 18)}}的其他基金
Microbial diversity, otitis media, and the pneumococcal transctiptome
微生物多样性、中耳炎和肺炎球菌转录组
- 批准号:
8205562 - 财政年份:2011
- 资助金额:
$ 20.75万 - 项目类别:
Molecular epidemiologic identification of pneumococcal tissue specific genes
肺炎球菌组织特异性基因的分子流行病学鉴定
- 批准号:
7587469 - 财政年份:2007
- 资助金额:
$ 20.75万 - 项目类别:
Molecular epidemiologic identification of pneumococcal tissue specific genes
肺炎球菌组织特异性基因的分子流行病学鉴定
- 批准号:
7383925 - 财政年份:2007
- 资助金额:
$ 20.75万 - 项目类别:
Molecular epidemiologic identification of pneumococcal tissue specific genes
肺炎球菌组织特异性基因的分子流行病学鉴定
- 批准号:
7777360 - 财政年份:2007
- 资助金额:
$ 20.75万 - 项目类别:
Molecular epidemiologic identification of pneumococcal tissue specific genes
肺炎球菌组织特异性基因的分子流行病学鉴定
- 批准号:
7263736 - 财政年份:2007
- 资助金额:
$ 20.75万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 20.75万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 20.75万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 20.75万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 20.75万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 20.75万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 20.75万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 20.75万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 20.75万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 20.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 20.75万 - 项目类别:
Operating Grants














{{item.name}}会员




